Skinvisible Inc (SKVI) 0.0415 $SKVI
Global Anti-Aging Product Market 2014-2018: Beiersdorf AG, L'Oreal, Phosphagenics, Procter & Gamble & Unilever Group Dominate the Market
M2 - Mon May 19, 8:39AM CDT
Research and Markets (http://www.researchandmarkets.com/research/76jcqj/global_antiaging) has announced the addition of the "Global Anti-Aging Product Market 2014-2018" report to their offering. The analysts forecast the Global Anti-aging Product market will grow at a CAGR of 6.7% over the period 2013-2018. One of the main drivers is the rising global aging population. This growth is resulting in an increase in the need for anti-aging and age-defying facial products. Consumers are increasingly using anti-aging products made from natural and organic ingredients. Over the years, consumers have started seeking safe products and are now paying more attention to the ingredients in the anti-aging products, preferring those that do not contain chemicals or ingredients that could cause harmful side effects. Typically, anti-aging skincare and hair care products are made from synthetic ingredients, additives, and fillers. Such products could harm skin and hair, or even weaken and loosen skin when it starts aging. Natural oils such as argan, marula, coconut, and almond are some popular ingredients used in organic products. As organic products have little harmful effects, many large companies are launching natural and organic products to gain more market share. Further, the report states that one of the main challenges hindering market growth is the intensifying competition in the market caused by the entrance of new players and private labels. Key Vendors - Beiersdorf AG - L'Or?al SA - Phosphagenics Ltd. - Procter & Gamble Co. - Unilever Group Other Prominent Vendors - Allergan Inc. - Amexdrug Corp. - Avon Products Inc. - Chanel SA - Christian Dior SA - Clarins USA Inc. - DS Healthcare Group Inc. - Elizabeth Arden Inc. - Ella Bach? - Est?e Lauder Co. Inc. - Henkel AG & Co KGaA - Jan Marini Skin Research Inc. - Johnson & Johnson Co. - Kao Corp. - NeoStrata Co. - NuSKin Enterprises - Orlane SA - Revlon Inc. - Robanda International Inc. - Shiseido Co. - SkinMedica Inc. - Skinvisible Inc. - Woodridge Labs Inc. For more information visit http://www.researchandmarkets.com/research/76..._antiaging
Skinvisible's Patent Pending Hand Sanitizer Approval Extended for Ten Years
Marketwire - Fri May 16, 1:52PM CDT
Skinvisible Pharmaceuticals, Inc. (OTCBB: SKVI) (OTCQB: SKVI) has received notification from the Federal Public Service (FPS) Health, Food Chain Safety and Environment in Belgium that it has extended the registration of DermSafe, its unique antimicrobial hand sanitizer, for an additional ten years; until December 31, 2024. This replaces the previous authorization which was granted for only two years. DermSafe is regulated in accordance with Biocidal Product Regulation (EU) No. 528/2012. BPR regulates the marketing and use of biocidal products and has put into place regulations to improve the use and safety of biocidal products marketed by member states in the European Union.
Skinvisible's Sunscreen Meets New FDA Guidelines for Broad Spectrum and 80 Minute Water-Resistant Claims
Marketwire - Tue Mar 25, 8:06AM CDT
Skinvisible Pharmaceuticals, Inc. (OTCBB: SKVI) (OTCQB: SKVI) is pleased to announce that it has successfully completed independent testing to validate its broad spectrum sunscreen claims according to new labeling guidelines by the Food and Drug Administration (FDA) which are designed to help reduce the incidents of skin cancer in the U.S.
OTC Signal Daily Stock Watch - Skinvisible Pharmaceuticals (OTCQB: SKVI)
WorldStockWire - Mon Sep 09, 1:45AM CDT
OTC Signal tracks stocks daily and is pleased to offer its stock alerts. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Signal at the following: http://www.otcsignal.com
Skinvisible Adds Additional Patent Protection to Its Topical Drug Delivery Technology
Marketwire - Wed Jun 26, 8:05AM CDT
Skinvisible Pharmaceuticals, Inc. (OTCQB: SKVI) today announced that it has expanded its US patent protection for Invisicare(R), its unique topical drug delivery technology. Skinvisible has been granted US Patent Number 8,481,058 for the topical composition precursor for Invisicare with an expiry date of June 28, 2021. The patent issued by the United States Patent and Trademark Office (USPTO) is a division of Skinvisible's US patent "Topical Composition, Topical Composition Precursor, and Methods for Manufacturing and Using." This new patent expands Skinvisible's patent portfolio to fourteen US and international patents and is one of a series of five patents (including Skinvisible's initial product patent) granted in the United States specifically protecting Invisicare and the products formulated with it.
Global Anti-Aging Product Market 2014-2018: Beiersdorf AG, L'Oreal, Phosphagenics, Procter & Gamble & Unilever Group Dominate the Market
M2 - Mon May 19, 8:39AM CDT
Research and Markets (http://www.researchandmarkets.com/research/76jcqj/global_antiaging) has announced the addition of the "Global Anti-Aging Product Market 2014-2018" report to their offering. The analysts forecast the Global Anti-aging Product market will grow at a CAGR of 6.7% over the period 2013-2018. One of the main drivers is the rising global aging population. This growth is resulting in an increase in the need for anti-aging and age-defying facial products. Consumers are increasingly using anti-aging products made from natural and organic ingredients. Over the years, consumers have started seeking safe products and are now paying more attention to the ingredients in the anti-aging products, preferring those that do not contain chemicals or ingredients that could cause harmful side effects. Typically, anti-aging skincare and hair care products are made from synthetic ingredients, additives, and fillers. Such products could harm skin and hair, or even weaken and loosen skin when it starts aging. Natural oils such as argan, marula, coconut, and almond are some popular ingredients used in organic products. As organic products have little harmful effects, many large companies are launching natural and organic products to gain more market share. Further, the report states that one of the main challenges hindering market growth is the intensifying competition in the market caused by the entrance of new players and private labels. Key Vendors - Beiersdorf AG - L'Or?al SA - Phosphagenics Ltd. - Procter & Gamble Co. - Unilever Group Other Prominent Vendors - Allergan Inc. - Amexdrug Corp. - Avon Products Inc. - Chanel SA - Christian Dior SA - Clarins USA Inc. - DS Healthcare Group Inc. - Elizabeth Arden Inc. - Ella Bach? - Est?e Lauder Co. Inc. - Henkel AG & Co KGaA - Jan Marini Skin Research Inc. - Johnson & Johnson Co. - Kao Corp. - NeoStrata Co. - NuSKin Enterprises - Orlane SA - Revlon Inc. - Robanda International Inc. - Shiseido Co. - SkinMedica Inc. - Skinvisible Inc. - Woodridge Labs Inc. For more information visit http://www.researchandmarkets.com/research/76..._antiaging
Skinvisible's Patent Pending Hand Sanitizer Approval Extended for Ten Years
Marketwire - Fri May 16, 1:52PM CDT
Skinvisible Pharmaceuticals, Inc. (OTCBB: SKVI) (OTCQB: SKVI) has received notification from the Federal Public Service (FPS) Health, Food Chain Safety and Environment in Belgium that it has extended the registration of DermSafe, its unique antimicrobial hand sanitizer, for an additional ten years; until December 31, 2024. This replaces the previous authorization which was granted for only two years. DermSafe is regulated in accordance with Biocidal Product Regulation (EU) No. 528/2012. BPR regulates the marketing and use of biocidal products and has put into place regulations to improve the use and safety of biocidal products marketed by member states in the European Union.
Skinvisible's Sunscreen Meets New FDA Guidelines for Broad Spectrum and 80 Minute Water-Resistant Claims
Marketwire - Tue Mar 25, 8:06AM CDT
Skinvisible Pharmaceuticals, Inc. (OTCBB: SKVI) (OTCQB: SKVI) is pleased to announce that it has successfully completed independent testing to validate its broad spectrum sunscreen claims according to new labeling guidelines by the Food and Drug Administration (FDA) which are designed to help reduce the incidents of skin cancer in the U.S.
OTC Signal Daily Stock Watch - Skinvisible Pharmaceuticals (OTCQB: SKVI)
WorldStockWire - Mon Sep 09, 1:45AM CDT
OTC Signal tracks stocks daily and is pleased to offer its stock alerts. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Signal at the following: http://www.otcsignal.com
Skinvisible Adds Additional Patent Protection to Its Topical Drug Delivery Technology
Marketwire - Wed Jun 26, 8:05AM CDT
Skinvisible Pharmaceuticals, Inc. (OTCQB: SKVI) today announced that it has expanded its US patent protection for Invisicare(R), its unique topical drug delivery technology. Skinvisible has been granted US Patent Number 8,481,058 for the topical composition precursor for Invisicare with an expiry date of June 28, 2021. The patent issued by the United States Patent and Trademark Office (USPTO) is a division of Skinvisible's US patent "Topical Composition, Topical Composition Precursor, and Methods for Manufacturing and Using." This new patent expands Skinvisible's patent portfolio to fourteen US and international patents and is one of a series of five patents (including Skinvisible's initial product patent) granted in the United States specifically protecting Invisicare and the products formulated with it.
